Suchergebnisse - "Zeng, Zhen"

PubPharm (15)

1

Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma : a propensity score matching analysis

enthalten in: Frontiers in oncology | 2024

von Li, Y. | Wei, S. | Fu, Y. | +9

2

Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus : a multicenter study

enthalten in: Frontiers in oncology | 2023

von Huang, L. | Zeng, Z. | Wu, J. | +10

3

Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus

enthalten in: Journal of hepatocellular carcinoma | 2023

von Chang, X. | Yu, S. | Pang, J. | +10

4

Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients : A Retrospective Study

enthalten in: Journal of hepatocellular carcinoma | 2022

von Chen, B. | Lei, J. | Zhao, H. | +8

5

The pan-cancer noninvasive screening and early detection by epigenetic techniques

enthalten in: Epigenomics | 2021

von Yang, Y. | Qin, Y. | Zeng, Z. | +4

6

Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels

enthalten in: Journal of hepatocellular carcinoma | 2021

von Cheng, J. | Li, Y. | Wang, X. | +10

7

Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment : A Report of Two Cases

enthalten in: OncoTargets and therapy | 2021

von Wu, T. | Zhang, L. | Zeng, Z. | +4

8

The expression level and diagnostic value of microRNA-22 in HCC patients

enthalten in: Artificial cells, nanomedicine, and biotechnology | 2020

von Zeng, Z. | Dong, J. | Li, Y. | +6

9

Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers

enthalten in: Therapeutic advances in medical oncology | 2020

von Song, L. | Chen, Y. | Gong, Y. | +6

10

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

enthalten in: Cancer management and research | 2018

von Chen, Y. | Zeng, Q. | Liu, X. | +10